Article
The economic benefits of FASB's recommended disclosures: Evidence from the pharmaceutical industry
Advances in Accounting
(2008)
Disciplines
- Economics,
- Finance and
- Accounting
Publication Date
December 1, 2008
DOI
10.1016/j.adiac.2008.08.007
Citation Information
Joseph Legoria, Jeff Boone and William W. Stammerjohan. "The economic benefits of FASB's recommended disclosures: Evidence from the pharmaceutical industry" Advances in Accounting Vol. 24 Iss. 2 (2008) p. 202 - 212 Available at: http://works.bepress.com/william-stammerjohan/10/